In peer-reviewed peptide literature, papers frequently celebrate statistically significant findings (e.g. P < 0.05). However, scientific literacy requires distinguishing statistical significance from clinical relevance.
What a P-Value Actually Tells Us:
A p-value reflects the probability of observing the trial data (or more extreme results) assuming that the null hypothesis—that there is no true difference between the treatment and placebo—is completely true. A p-value below 0.05 simply suggests that the observed outcome is unlikely to have arisen purely from random sampling chance.
The Influence of Sample Size:
With a large enough sample size (e.g. 10,000 participants), an extremely trivial physiological change—such as a 0.2% change in muscle cross-sectional area or a 0.3 mmHg shift in blood pressure—can achieve a p-value of P < 0.001. While statistically robust, this shift may be clinically unnoticeable to a patient.
Effect Size and Minimal Clinically Important Difference (MCID):
Clinicians evaluate whether an outcome meets the Minimal Clinically Important Difference (MCID). For instance, in anti-obesity trials, the FDA and European regulatory bodies require an active intervention to demonstrate a placebo-subtracted mean weight loss of at least 5% to be considered clinically meaningful.